🟢 Definium Therapeutics is trading 4.1% up today amid broader risk-on sentiment

Definium Therapeutics is trading 4.1% up now at $39.27, broadly aligning with stronger market sentiment on September 11, 2026.

• The S&P 500, Nasdaq Composite, and Dow Jones are each up roughly 1%, supporting a global risk-on explanation.
• On September 10, the company announced it will present Phase 3 Emerge and Voyage topline data at Psych Congress 2026.
• No new September 11 company-specific catalyst was identified.